Back to School: How biopharma can reboot drug development. Access exclusive analysis here
INDICATION: Cytokine release syndrome (CRS)
Mouse studies suggest down-regulating catecholamines with NPPA or the TYH inhibitor Demser could
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury